National Institute for Health and Welfare 2229500-6 PL 30 Helsinki 00271 jenni.tiainen@thl.fi https://thl.fi/en/web/thlfi-en Pneumococcal 13-Valent Conjugate Vaccin (PCV13) THL/524/8.00.02/2018 The scope of the procurement is the delivery of the Pneumococcal 13-valent conjugate vaccine required for the vaccination programme in Finland for the period 2018-2020 and for option period 2021-2022. 286200.00 A direct award procedure is applied because there is only one Supplier on the market able to supply an article that fulfills the set requirements. The National Institute for Health and Welfare (henceforth “THL”) will implement the procurement on the Ministry of Social Affairs and Health (henceforth “STM”) side. A direct award procedure is applied because there is only one Supplier on the market able to supply an article that fulfills the set requirements. 1 Pneumococcal 13-Valent Conjugate Vaccin (PCV13) 2018-04-24 Pfizer Oy 0194053-9 Helsinki 286200 The Market Court Radanrakentajantie 5 Helsinki 00520 +358 295643300 markkinaoikeus@oikeus.fi +358 295643314 http://www.markkinaoikeus.fi/en/index.html 2018-05-03
See tender at TED: http://ted.europa.eu/udl?uri=TED:NOTICE:193359-2018:TEXT:EN:HTML
Piesakieties Mercell un saņemiet paziņojumus par jaunākajiem iepirkumiem sev svarīgajās nozarēs 7 dienas bez maksas!